The Biden Administration is postponing for one year the deadline of the first in an ongoing series of required annual reports from government-sponsored and commercial health plans to the federal government disclosing drug manufacturer rebates and their impact on health coverage premiums.
The initial reports, which will include 2020 and 2021 data, now are due 27 December 2022, instead of 27 December...






